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Aims: The aim of this study was to investigate whether the background intakes of total dietary fat, monounsaturated
fatty acids (MUFA) and polyunsaturated fatty acids (PUFA) modulate the effects of dietary saturated fatty acids (SFA) on
metabolic syndrome (MetS).
Material and methods: This population-based cross-sectional study was conducted on a representative sample of 4
677 adults, aged 19 to 84 years. MetS was defined according to the ATP III criteria.
Results: Median intakes of SFA, MUFA and PUFA were 9.5, 9.6 and 5.6% of total energy. High SFA intakes were
associated with higher prevalence of MetS, in both individuals with higher and lower median intakes of total fat,
MUFA and PUFA.
Conclusions: Our findings indicate that SFA intakes were positively associated with the prevalence of MetS,
independent of total dietary fat, MUFA and PUFA intake.
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InteractionBackground
Metabolic syndrome (MetS), a constellation of metabolic
abnormalities including glucose intolerance, abdominal
obesity, dyslipidemia and hypertension [1], is highly
prevalent in Iran. With a prevalence of over 30 % in the
adult population, this epidemic is foreseen to continue
to escalate over the next decade [2]. Health problems as-
sociated with this syndrome include diabetes and cardio-
vascular disease [3]. Although the optimal dietary
pattern to reduce progression of MetS has not been well
established, a reduction in the proportion of calories
from fat, particularly saturated fatty acids (SFA) is gener-
ally recommended [4]. Previous studies suggest that re-
ducing the consumption of SFA may be more effective
in the prevention of cardiometabolic risk factors [5, 6].
However, the results of recent studies have been* Correspondence: mirmiran@endocrine.ac.ir
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unless otherwise stated.conflicting regarding the relative effect of SFA intake on
cardiometabolic risk factors; some report no effect [7, 8],
while others found a beneficial effect [9, 10]. Background
intake of dietary monounsaturated fatty acids (MUFA)
and polyunsaturated fatty acids (PUFA) may affect these
associations [10, 11]. A recent prospective study investi-
gating the interaction between nutrients and risk of cor-
onary atherosclerosis found that intake of SFA was
associated with less progression of coronary atheroscler-
osis, an association that was significant only among sub-
jects consuming less MUFA [10]. Also in a clinical trial,
after categorizing the subjects by the median energy fat
percentage, no significant difference was found in high
fat diets compared with low fat diets, between the effect
of the high SFA and high MUFA diets on insulin sensi-
tivity [12]. An experimental study showed that dietary
unsaturated fatty acids interfere with SFA in expression
of inflammatory markers [13].
However, previous studies have shown no significant
interaction between dietary SFA and PUFA on cardio-
metabolic risk factors [10, 11]. In a clinical trial study,n Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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gardless of whether the diet contained high or low
amounts of SFA [11]. Considering the limited data avail-
able on the association between interaction of SFA,
MUFA, PUFA and MetS, the aim of this study was to in-
vestigate whether background intakes of total dietary fat,
MUFA and PUFA modulate the effects of dietary SFA
on the MetS and its components, among 19–84 year old
subjects, participants of the Tehran Lipid and Glucose
Study (TLGS).
Methods
This population based cross-sectional study, conducted
within the framework of the TLGS, an ongoing
community-based prospective investigation, included a
sample of residents under the coverage of 3 medical
health centers in District No. 13 of Tehran, the capital
city of Iran. The design of the study has been described
previously [14]. Briefly, using multistage cluster random
sampling methods, 15 005 people, aged ≥ 3 years, were
selected and followed up every 3 years. During the
fourth phase of the TLGS (2008–2011), a total of 12 823
subjects completed the examinations and were invited to
complete the food frequency questionnaire (FFQ); of theTotal number of participants in the 
4th phase of TLGS: 12 823 
Participants with completed 
FFQs: 7 956 
Participants aged 19-84: 5 319 
P
En
Final sample for analysis: 4 677 
Pa
Fig. 1 Outline of the selection design of study participants7 956 who agreed to participate and completed the FFQ,
5 319 were aged 19–84 years. Participants were excluded
if they were on any specific diets due to medical history
of myocardial infarction (n = 33), stroke (n = 6), cancer
(n = 7), reported daily energy intakes outside the range
of 800–4200 kcal/d (n = 322) and for missing data on
physical activity, or any of anthropometrical measure-
ments, and biochemical variables (n = 92). Also excluded
were participants with hyperlipidemia, hyperglycemia
and hypertension that had changed their dietary intake
(n = 182). Finally, data for 4677 individuals (2075 males
and 2602 females) were analyzed (Fig. 1). The design of
the study was approved by the ethical committee of the
Research Institute for Endocrine Sciences, Shahid
Beheshti University of Medical Sciences, and informed
written consent was obtained from all participants.
Dietary assessment
Usual dietary intake was assessed using a 147-item vali-
dated semi-quantitative FFQ. The validity and reliability
of the FFQ have been described in detail elsewhere [15].
The FFQ consists of a list of foods with a standard serv-
ing size, commonly consumed by Iranians. Trained dieti-
cians with at least 5 years of experience in the TLGSExcluded:  
articipants with aged 3-18 y: 2637 
Subject excluded:  
Myocardial infarction: 33 
Stroke: 6 
Cancer: 7 
Hypertension, hyperglycemia, and 
hyperlipidemia: 182 
ergy intake outside the range of 800-4200 
kcal: 322 
Incomplete data: 92 
Excluded:  
rticipants with incomplete FFQs: 4867 
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views, asking participants to report their frequency of
consumption of a given serving of each food item during
the previous year on a daily, weekly, or monthly basis
[16]. Details on dietary fat intakes, i.e. type of foods con-
sumed e.g. full fat vs. fat free were obtained. The re-
ported frequency for each food item was converted to a
daily intake. Portion sizes of consumed food were then
converted to grams using household measures [17]. En-
ergy of each gram of food was obtained from the US De-
partment of Agriculture’s (USDA) Food Composition
Table (FCT) by multiplying the gram of consumption of
each food by the content of energy per 100 g and total
energy intake was calculated by summing up energy in-
takes from all foods. Composition values for SFA, MUFA
and PUFA were obtained from the USDA FCT, because
the Iranian FCT with regard to fatty acid intakes is in-
complete. Among food items in the FFQ, only ‘kashk’
was not listed in the USDA FCT, and its content of total
fatty acid and SFA was determined from the nutritional
facts given for this product.
Validity and reliability of the FFQ were assessed in a
random sample of 132 subjects, aged 20 y and over. The
validity and reliability of the FFQ for total dietary fat
was acceptable [18]; correlation coefficient between the
FFQ and multiple 24-h recalls was 0.59 and 0.38; and
between the two FFQs was 0.43 and 0.42, in males and
females, respectively [15]. Also intraclass correlations be-
tween the two FFQs and between multiple 24 recalls and
the FFQ for SFA, MUFA and PUFA were acceptable in
both genders (range 0.51 to 0.74).
Biochemical assessment
After 12 to 14 h of overnight fasting, blood samples were
drawn into vacutainer tubes in a sitting position, from
all study participants. All blood analyses were done at
the TLGS research laboratory on the day of blood collec-
tion, using a Selectra 2 autoanalyzer (Vita; Scientific,
Spankeren, the Netherlands). Serum triglyceride concen-
trations were measured using triglyceride kits (Pars
Azmoon Inc., Tehran, Iran) by the enzymatic calorimetric
test with glycerol phosphate oxidase. HDL cholesterol was
measured after precipitation of the apolipoprotein B-
containing lipoproteins with phosphotungistic acid. Serum
fasting glucose concentration was assayed using an en-
zymatic colorimetric method with the glucose oxidase
technique. Inter- and intra-assay coefficients of variations
were both 2.2 % for serum glucose, 2 and 0.5 % for HDL-
C and 1.6 and 0.6 % for triglycerides, respectively.
Assessment of other variables
Weight was measured while the subjects were minimally
clothed and not wearing shoes, using digital scale and
was recorded to the nearest 100 g. Height was measuredwhile subjects were standing without shoes, with their
shoulders in a normal position, using a tape fixed to the
wall and was recorded to the nearest 0.5 cm. Body mass
index (BMI) was calculated as weight (kg) divided by
square of height (m2). Waist circumference (WC) was
measured at the level of the umbilicus site, using an out-
stretched tape meter, without pressure to body surfaces
and was recorded to the nearest 0.5 cm.
Systolic and diastolic blood pressure was measured
using a standard mercury sphygmomanometer, on the
right arm after a 15-min rest in a sitting position. Two
measurements were taken at 1-min intervals and the
average of measurement was recorded as the partici-
pant’s blood pressure. Physical activity was assessed
using a questionnaire, including a list of common activ-
ities of daily life; the frequency and amount of time of
activities spent per week over the past 12 month were
documented [19]. Levels of physical activity were
expressed as metabolic equivalent hours per week
(METs h/week) [20] and were categorized as light (>3
METs h/week), moderate (3–6 METs h/week) and heavy
(≥6 METs h/week) [20]. Cigarette smoking status was
categorized as current smoker, non-smoker and ex-
smoker. Additional covariate information including age,
medical history, and current use of medications was ob-
tained using an interview questionnaire.
Definition of MetS
MetS was defined as the presence of ≥ 3 of the following 5
components, as recommended by the Adult Treatment
Panel III [1]: 1. Low serum HDL cholesterol (<40 mg/dl in
men and < 50 mg/dl in women); 2. High serum triglyceride
concentrations (≥150 mg/dl); 3. Elevated blood pressure
(≥130/85 mmHg); 4. Impaired fasting glucose (fasting
plasma glucose concentrations ≥ 110 mg/dl), and 5. En-
larged waist circumference. The cutoff for waist circumfer-
ence was adopted from the new description of abdominal
obesity for Iranian adults, i.e. 95 cm for both genders [21].
Statistical analysis
The Statistical Package for Social Science (version 15.0;
SPSS Inc, Chicago IL) was used for all statistical analyses.
Significant differences in characteristics and dietary intakes
in the categories of total fat intake and SFA using joint cat-
egories of higher (≥ median) versus lower (< median) in-
takes were evaluated using one-way analysis of variance for
continuous variables and values were reported as Mean
(SD). Chi-square test was used to detect any significant dif-
ferences in the distribution of participants across quartile
categories with regard to qualitative variables.
Odds Ratio (ORs) and their 95 % confidence inter-
vals was estimated for the MetS and its components,
according to both unsaturated fatty acids (MUFA and
PUFA) and SFA using joint categories of higher median
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able logistic regression models. In all multivariate
models, subjects with lower median intakes of both un-
saturated fatty acids (MUFA and PUFA) and SFA were
considered as the reference.
Result
Of 4677 study participants, 44.4 % were male and 55.6 %
were female, with a mean age (SD) of 41.7 (13.9) yearsTable 1 Characteristics and dietary intakes of participants of the Teh
intakes
SFA <median
Total fat < median Total fa
Participants (n) 1255 1097
Age (y) 44.3 ± 14.4a 42.3 ±





Current smoker (%) 7.9 8.2
BMI (kg/m2) 27.5 ± 4.6 27.3 ±
Dietary intakeb
Total energy intake (Kcal/d) 2329 ± 19.5 2447 ±
Protein (% of total energy intake) 15.2 ± 0.2 14.3 ±
Carbohydrate (% of total energy intake) 64.0 ± 0.2 59.2 ±
Total fat (% of total energy intake) 26.1 ± 0.3 32.8 ±
SFA (% of total energy intake) 7.5 ± 0.3 7.9 ± 0
MUFA (% of total energy intake) 7.7 ± 0.3 10.1 ±
PUFA(% of total energy intake) 4.4 ± 0.3 7.2 ± 0
Cholesterol (mg/d) 186 ± 3.1 185 ± 3
Fiber (g/d) 30.4 ± 15.2 29.0 ±
Fruit 252 ± 7.6 279 ± 8
Vegetables 278 ± 5.1 278 ± 5
Meat, poultry and fish 60.9 ± 1.2 65.6 ±
Whole grain 179 ± 3.0 133 ± 3
Refine grain 351 ± 4.2 291 ± 4
Dairy products 362 ± 5.8 558 ± 6
Legumes 46.8 ± 1.2 55.8 ±
Nuts 5.6 ± 0.3 5.8 ± 0
Hydrogenated vegetable oils 31.5 ± 0.3 40.2 ±
Non-hydrogenated vegetable oils 19.2 ± 0.7 21.5 ±
Levels of physical activity were expressed as metabolic equivalent hours per week (
h/week) and heavy (>6 METs h/week)
Grouped according to < or ≥median of both Total fat (29.5 % of total energy) and S
intakes of both MUFA and SFA
BMI body mass index, SFA saturated fatty acid, MUFA monounsaturated fatty acid
*P value was compared the characteristics across quartiles, using analysis of ANOVA
aValues are Mean (SE), except for variables determined
bDietary intake were adjusted for age, gender and total energy intake using the ANand had mean BMI of 27.2 (4.7) kg/m2. The reported
mean (SD) daily intakes were: Total fat 29.9 (6.1) % of
total energy intake; SFA 10.2 (2.8) % of total energy in-
take; MUFA 10.2 (2.8) % of total energy intake and
PUFA 6.1 (1.9) % of total energy intake. Baseline charac-
teristics and dietary intakes of the participants according
to both total fat and SFA intakes are shown in Table 1.
Compared to participants with lower intakes of both
SFA and total fat, those with high intake of both SFAran Lipid and Glucose study, according to Total fat and SFA
SFA≥median
t≥median Total fat < median Total fat≥median P*
1010 1315






4.8 27.1 ± 4.8 27.1 ± 4.8 0.06
21.0 2287 ± 21.7 2425 ± 19.9 0.09
0.2 16.0 ± 0.2 15.1 ± 0.2 <0.005
0.2 57.6 ± 0.2 54.0 ± 0.2 <0.005
0.4 31.0 ± 0.4 38.3 ± 0.3 <0.005
.4 11.8 ± 0.4 12.4 ± 0.4 <0.005
0.4 9.7 ± 0.4 12.7 ± 0.3 <0.005
.4 4.5 ± 0.4 7.9 ± 0.3 <0.005
.2 273 ± 3.4 258 ± 3.1 <0.005
15.0 24.1 ± 12.8 20.6 ± 12.5 <0.005
.2 285 ± 8.5 226 ± 7.8 <0.005
.7 302 ± 5.5 264 ± 5.2 <0.005
1.4 61.5 ± 1.3 63.2 ± 1.3 <0.005
.3 144 ± 3.2 111 ± 3.0 <0.005
.7 239 ± 4.5 279 ± 4.3 <0.005
.5 293 ± 6.3 449 ± 6.0 <0.005
1.2 52.8 ± 1.2 42.3 ± 1.2 <0.005
.3 10.6 ± 0.3 9.9 ± 0.3 <0.005
0.3 35.1 ± 0.4 49.5 ± 0.5 <0.005
0.6 18.5 ± 0.5 23.8 ± 0.5 <0.005
METs h/week) and categorized as light (<3 METs h/week), moderate (3–6 METs
FA (9.5 % of total energy), with the reference group intake being <median
(for age, BMI and dietary intake) and chi-square test (for categorized variables)
COVA analysis, except for total energy intake (adjusted for age and gender)
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significant differences in the physical activity, smoking
status, and BMI. Those subjects with high intakes of
both SFA and total fat, consumed less carbohydrate,
fiber, fruit, vegetable, whole grain, legume and more
total fat and SFA, hydrogenated vegetable oils and non
hydrogenated vegetable oils (Table 1).
Table 2 showed the odds ratio of the MetS and its
components according to intakes of both SFA and total
fat intakes. After adjustment for lifestyle and dietary
confounders, high SFA intake (≥9.5 % of total energy)
was associated with a 39 % higher prevalence of MetS,
among subjects with lower total fat intake (95 % CI:
1.11-1.74) and 22% higher among subjects with a higher
total fat intake (95 % CI: 1.05-1.55), compared with sub-
jects with lower intakes of both. Also the combinationTable 2 Odds ratio and 95 % confidence interval for metabolic synd
intakes among participants of the Tehran Lipid and Glucose studya
SFA <median
Total fat < median T
Enlarged waist circumference
Model 1 1 1
Model 2 1 1
Model 3 1 0
Low serum HDL cholesterol
Model 1 1 1
Model 2 1 1
Model 3 1 0
Abnormal glucose homeostasis
Model 1 1 0
Model 2 1 0
Model 3 1 0
Elevated blood pressure
Model 1 1 1
Model 2 1 1
Model 3 1 1
High serum triglyceride concentrations
Model 1 1 1
Model 2 1 1
Model 3 1 0
Metabolic syndrome
Model 1 1 1
Model 2 1 1
Model 3 1 0
Model 1 was crude
Model 2 was adjusted for gender, age, smoking status, physical activity, total energ
protein, percentage of energy from polyunsaturated fatty acid, total fiber, and chole
Model 3 was further adjusted for BMI
SFA saturated fatty acid
aGrouped according to < or ≥median of both total fat (29.5 % of total energy) and
intakes of both PUFA and SFAof a high SFA and total fat intakes was associated with
abnormal glucose homeostasis, elevated blood pressure,
and high serum triglyceride concentrations after adjust-
ment for confounding factors.
ORs of the MetS and its components according to in-
takes of both MUFA and SFA is shown in Table 3. After
adjustment for confounding factors, high SFA intake
(≥9.5 % of total energy) was associated with higher
prevalence of abnormal glucose homeostasis and MetS,
whether MUFA intakes was lower or higher than the
median intake. Also the combination of a high SFA in-
takes and a low MUFA intakes was associated with high
serum triglyceride concentrations, after adjustment for
confounding factors.
Table 4 showed the odds ratio of MetS and its compo-
nents according to both PUFA and SFA intakes. Afterrome and its components according to total fat and SFA
SFA≥median
otal fat≥median Total fat < median Total fat≥median
.35 (1.11-1.65) 1.57 (1.37-1.80) 1.40 (1.16-1.67)
.24 (1.00-1.54) 1.40 (1.17-1.69) 1.30 (1.07-1.57)
.99 (0.71-1.37) 1.26 (0.96-1.66) 1.37 (1.02-1.83)
.10 (0.91-1.34) 1.07 (0.93-1.22) 1.00 (0.83-1.19)
.01 (0.81-1.25) 0.90 (0.74-1.10) 0.95 (0.78-1.14)
.97 (0.78-1.21) 0.86 (0.71-1.04) 0.91 (0.75-1.11)
.94 (0.74-1.19) 1.31 (1.13-1.53) 1.50 (1.23-1.84)
.97 (0.75-1.25) 1.32 (1.07-1.63) 1.38 (1.11-1.70)
.87 (0.67-1.14) 1.22 (0.98-1.52) 1.32 (1.06-1.65)
.31 (1.04-1.64) 1.29 (1.05-1.60) 1.49 (1.27-1.74)
.29 (1.01-1.65) 1.22 (0.98-1.52) 1.44 (1.17-1.77)
.17 (0.91-1.52) 1.15 (0.91-1.45) 1.32 (1.06-1.64)
.24 (1.00-1.53) 1.18 (0.97-1.44) 1.73 (1.50-2.00)
.06 (0.84-1.34) 1.10 (0.90-1.35) 1.42 (1.16-1.73)
.99 (0.77-1.27) 1.04 (0.84-1.29) 1.36 (1.10-1.68)
.16 (0.93-1.45) 1.66 (1.44-1.93) 1.40 (1.15-1.71)
.09 (0.86-1.38) 1.50 (1.23-1.83) 1.29 (1.10-1.59)
.92 (0.70-1.21) 1.39 (1.11-1.74) 1.22 (1.05-1.55)
y intake, percentage of energy from carbohydrate, percentage of energy from
sterol
SFA (9.5 % of total energy), with the reference group intake being <median
Table 3 Odds ratio and 95 % confidence interval for metabolic syndrome and its components according to MUFA and SFA intakes
among participants of the Tehran Lipid and Glucose studya
SFA <median SFA≥median
MUFA <median MUFA≥median MUFA <median MUFA≥median
Enlarged waist circumference
Model 1 1 1.08 (0.91-1.28) 1.60 (1.37-1.87) 1.34 (1.14-1.58)
Model 2 1 1.02 (0.85-1.22) 1.38 (1.14-1.68) 1.21 (1.01-1.45)
Model 3 1 0.91 (0.70-1.20) 1.25 (0.94-1.68) 1.24 (0.94-1.63)
Low serum HDL cholesterol
Model 1 1 0.97 (0.82-1.14) 1.05 (0.90-1.23) 0.97 (0.83-1.14)
Model 2 1 0.94 (0.79-1.12) 0.90 (0.74-1.10) 0.88 (0.74-1.06)
Model 3 1 0.93 (0.78-1.11) 0.87 (0.71-1.05) 0.86 (0.72-1.03)
Abnormal glucose homeostasis
Model 1 1 0.90 (0.73-1.10) 1.32 (1.10-1.58) 1.33 (1.11-1.60)
Model 2 1 0.96 (0.77-1.18) 1.39 (1.12-1.74) 1.30 (1.06-1.59)
Model 3 1 0.92 (0.74-1.14) 1.30 (1.03-1.63) 1.26 (1.02-1.55)
Elevated blood pressure
Model 1 1 0.98 (0.80-1.19) 1.43 (1.20-1.71) 1.23 (1.02-1.48)
Model 2 1 0.95 (0.77-1.17) 1.30 (1.05-1.63) 1.13 (0.92-1.39)
Model 3 1 0.91 (0.73-1.13) 1.20 (0.95-1.51) 1.08 (0.87-1.33)
High serum triglyceride concentrations
Model 1 1 1.12 (0.94-1.35) 1.76 (1.49-2.07) 1.38 (1.16-1.64)
Model 2 1 1.01 (0.83-1.22) 1.36 (1.10-1.68) 1.19 (0.98-1.44)
Model 3 1 1.00 (0.81-1.22) 1.30 (1.05-1.63) 1.16 (0.95-1.42)
Metabolic syndrome
Model 1 1 0.97 (0.80-1.17) 1.64 (1.38-1.94) 1.39 (1.17-1.67)
Model 2 1 0.93 (0.76-1.14) 1.44 (1.17-1.78) 1.26 (1.14-1.53)
Model 3 1 0.87 (0.69-1.08) 1.33 (1.05-1.68) 1.22 (1.05-1.52)
Model 1 was crude
Model 2 was adjusted for gender, age, smoking status, physical activity, total energy intake, percentage of energy from carbohydrate, percentage of energy from
protein, percentage of energy from polyunsaturated fatty acid, total fiber, and cholesterol
Model 3 was further adjusted for BMI
SFA saturated fatty acid, MUFA monounsaturated fatty acid
aGrouped according to < or ≥median of both MUFA (9.6 % of total energy) and SFA (9.5 % of total energy), with the reference group intake being <median
intakes of both PUFA and SFA
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SFA intake (≥9.5 % of total energy) was associated with
higher prevalence of MetS, in both participants with
higher and lower median intakes of PUFA. Also high
SFA intake (≥9.5 % of total energy) was associated with
higher prevalence of abnormal glucose homeostasis,
whether PUFA intakes was lower or higher.
Discussion
The aim of the current study was to investigate whether
the background intake of total dietary fat, MUFA and
PUFA modulates the effects of SFA on the MetS and its
components. Our findings showed that among Tehra-
nian adults, dietary SFA was associated with high preva-
lence of the MetS and intake of total dietary fat, MUFA
and PUFA (higher or lower than the median) did notaffect the this association. Also the combination of a
high SFA and total fat intakes was associated with ab-
normal glucose homeostasis, elevated blood pressure,
and high serum triglyceride concentrations after adjust-
ment for confounding factors.
In prospective studies, dietary SFA has been consid-
ered a cardiometabolic risk factors [5, 6], but review of
the current evidence indicates surprisingly controversial
findings; some report no effect [7, 8], while a few found
beneficial effects of dietary SFA on chronic disease [9,
10]. Types of dietary fats tend to be intercorrelated and
therefore background intakes of dietary MUFA and
PUFA may affect the association between dietary SFA
and cardiometabolic risk factors [13, 23]. In the only
large cohort study with a 14 year follow up, SFA intake
was positively associated with chronic heart disease, but
Table 4 Odds ratio and 95 % confidence interval for metabolic syndrome and its components according to PUFA and SFA intakes
among participants of the Tehran Lipid and Glucose studya
SFA <median SFA≥median
PUFA <median PUFA≥median PUFA <median PUFA≥median
Enlarged waist circumference
Model 1 1 1.08 (0.91-1.28) 1.06 (0.71-1.27) 1.24 (0.94-1.63)
Model 2 1 1.02 (0.85-1.22) 1.04 (0.70-1.25) 1.21 (0.88-1.45)
Model 3 1 0.91 (0.70-1.20) 0.99 (0.69-1.22) 1.04 (0.70-1.58)
Low serum HDL cholesterol
Model 1 1 0.97 (0.83-1.14) 1.05 (0.90-1.23) 0.97 (0.82-1.14)
Model 2 1 0.88 (0.74-1.06) 0.90 (0.74-1.10) 0.94 (0.79-1.12)
Model 3 1 0.86 (0.72-1.03) 0.87 (0.71-1.05) 0.93 (0.78-1.11)
Abnormal glucose homeostasis
Model 1 1 0.90 (0.73-1.10) 1.32 (1.15-1.58) 1.37 (1.11-1.60)
Model 2 1 0.96 (0.77-1.18) 1.26 (1.09-1.44) 1.30 (1.06-1.59)
Model 3 1 0.92 (0.74-1.14) 1.15 (1.06-1.33) 1.26 (1.02-1.55)
Elevated blood pressure
Model 1 1 1.23 (0.98-1.48) 1.43 (1.20-1.71) 0.98 (0.80-1.19)
Model 2 1 1.13 (0.92-1.39) 1.30 (0.95-1.63) 0.95 (0.77-1.17)
Model 3 1 1.08 (0.87-1.33) 1.20 (0.85-1.51) 0.91 (0.73-1.13)
High serum triglyceride concentrations
Model 1 1 1.38 (1.16-1.64) 1.26 (0.79-2.07) 1.12 (0.94-1.35)
Model 2 1 1.19 (0.98-1.44) 1.16 (0.70-1.68) 1.01 (0.83-1.22)
Model 3 1 1.16 (0.95-1.42) 1.10 (0.55-1.63) 1.00 (0.81-1.22)
Metabolic syndrome
Model 1 1 0.97 (0.80-1.17) 1.64 (1.38-1.94) 1.39 (1.17-1.67)
Model 2 1 0.93 (0.76-1.14) 1.44 (1.17-1.78) 1.26 (1.10-1.53)
Model 3 1 0.87 (0.69-1.08) 1.33 (1.05-1.68) 1.22 (1.05-1.52)
Model 1 was crude
Model 2 was adjusted for gender, age, smoking status, physical activity, total energy intake, percentage of energy from carbohydrate, percentage of energy from
protein, percentage of energy from polyunsaturated fatty acid, total fiber, and cholesterol
Model 3 was further adjusted for BMI
SFA saturated fatty acid, PUFA polyunsaturated fatty acid
aGrouped according to < or ≥median of both PUFA (5.6 % of total energy) and SFA (9.5 % of total energy), with the reference group intake being <median
intakes of both PUFA and SFA
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nificant after adjustment for intakes of polyunsaturated
fat [23]. A recent prospective study, which investigated
the interaction between nutrients and risk of progression
of coronary atherosclerosis, found SFA intake to be asso-
ciated with less progression of coronary atherosclerosis,
only significant among subjects consuming less MUFA
[10]; the finding was contrary to ours showing that in-
take of SFA increased the risk of MetS, independent of
total dietary fat and MUFA and PUFA [10, 23].
Results on the replacement of MUFA with SFA on car-
diometabolic risk factors were inconsistent [12, 24–26].
The effect of substation of SFA by MUFA on cardiomet-
abolic risk factors may be modulated by total dietary fat
[12]. In the KANWN multicenter study, after categoriz-
ing the subjects by the median energy fat percentage, inthe low fat intake group, high MUFA diet increased insu-
lin sensitivity by 20 %, compared to the high SFA diet;
however in the high fat diet, no significant difference was
found between the effect of the high SFA and high MUFA
diet on insulin sensitivity [12]. An observational study also
found that changes in insulin resistance were modified by
total fat intake, with an improvement in subjects with total
fat intake < 35.5% of total energy and no association in
subjects with total fat intake > 35.5% of total energy [27],
findings consistent with our results. Our findings was
showed dietary SFA to be associated with a higher preva-
lence of abnormal glucose homeostasis, elevated blood
pressure, and high serum triglyceride concentrations, only
among subject with high intake of total dietary fat.
Our findings show high prevalence of MetS and ab-
normal glucose homeostasis among subjects with high
Hosseinpour-Niazi et al. Journal of Health, Population and Nutrition  (2015) 33:5 Page 8 of 9intake of SFA, independent of dietary PUFA. Consistent
with our results, epidemiologic and experimental stud-
ies have shown no significant interaction between SFA
and PUFA [10, 11]. In a clinical trial study, fish oil had
a beneficial effect on some lipid profiles, regardless of
whether the diet containing high or low amounts of
SFA [11].
Our study has several strengths. In the current study,
we evaluate whether total dietary fat, PUFA and MUFA
intakes influence relations between SFA and Mets and
its components. We found that the association between
the SFA intake and some components of MetS is modu-
lated by total dietary fat, as suggested by some previous
studies [12, 27]. Also, our findings suggest that dietary
SFA was associated with MetS, independent of PUFA
and MUFA intake, which may have important implica-
tions for MetS prevention in populations.
Some limitations should be considered, one being the
use of UASD FCT to determine the intakes of PUFA,
MUFA and SFA, because of not having a complete Iran-
ian FCT. Given the cross-sectional design, we could not
determine causality between interaction of different type
of fatty acids and the MetS and its components. Future
studies using longitudinal data are needed to determine
these effects. In addition, this study included only
healthy adults, and our findings cannot be extrapolated
to other populations.
Conclusion
Our findings indicate that SFA intakes were positively
associated with the prevalence of MetS, independent of
total dietary fat, MUFA and PUFA intake. However total
dietary fat may modulate the association between SFA
and some components of MetS, results emphasizing that
both the quality and quantity of dietary fat are relevant
with Mets and cardiometabolic risk factors.
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